Find a Doctor
P.O. Box 800709,
Charlottesville, VA, 22908-0709
Phone: 434.924.9370 Fax: 434.924.5539
Training & Certification
General Surgery, Hospital of the University of Pennsylvania
Transplantation Surgery, University of Minnesota Hospital
- Surgery, 1990
General Surgery, Islet Transplant, Kidney Transplant, Pancreas Transplant, Peripheral Vascular Disease, Vascular Disorders/Procedures
Islet transplantation, Transplantation tolerance, Gene therapy, Xenotransplantation, Transplant immunosuppression, Chronic allograft nephropathy, Transplantation in patients with HIV
Kenneth L. Brayman, MD, PhD, FACS, is the division chief of Transplant Surgery at UVA. He is the director of the renal, pancreas and islet transplant programs and the Center for Cellular Transplantation and Therapeutics.He's also the Nabi Professor of Transplantation.
Dr. Brayman received his medical and doctorate degrees from the University of Pennsylvania School of Medicine. He completed his internship and residency in general surgery at the Hospital of the University of Pennsylvania and fellowships in transplantation surgery and surgical endoscopy at the University of Minnesota Hospital.
He is board certified by the American Board of Surgery and the National Board of Medical Examiners. He serves on numerous committees and is a member of professional and scientific societies including American Association of Kidney Patients, American Pancreatic Association and American Society of Transplant Physicians. Dr. Brayman is also a founding member of the International Pancreas and Islet Transplant Association. He is widely published in scientific and professional journals on topics related to his research and clinical experience.
Dr. Brayman has over twenty years of experience as a principal investigator in basic and translational research and clinical trials. His research interests include transplant immunosuppression, chronic allograft nephropathy, solid organ transplantation in patients with HIV, islet cell transplantation, transplantation tolerance, gene therapy and xenotransplantation. He was responsible for developing and establishing the Islet Isolation GMP Facility at UVA, and he has overseen the allo- and auto-transplantation of islets in more than 20 recipients. The Islet Transplant Program, headed by Dr. Brayman, uses an FDA-approved Human Islet Isolation class 10,000 GMP Facility at UVA for the isolation of clinical-grade pancreatic islets for transplants and currently participates with the NIH-sponsored Collaborative Islet Transplant Registry (CITR).